Abstract
Obtaining blood and cerebrospinal fluid is generally less invasive than standard tumor biopsy, and are increasingly used to develop surrogate biomarkers. Leptomeningeal disease, a devastating complication of cancer, represents a unique opportunity for using liquid biopsies for diagnosis, treatment, and to elucidate underlying mechanisms of resistance to therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2083-2084 |
| Number of pages | 2 |
| Journal | Clinical Cancer Research |
| Volume | 26 |
| Issue number | 9 |
| DOIs | |
| State | Published - May 1 2020 |
ASJC Scopus subject areas
- Oncology
- Cancer Research